Hentemann; Martin F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hentemann; Martin F..The latest application filed is for "pyrimidyl cyclopentanes as akt protein kinase inhibitors".

Company Profile

2.15.12

Hentemann; Martin F. - Boulder CO
Hentemann; Martin F. - Carlisle MA US
- Lafayette CO US
Hentemann; Martin F. - Lafayette CO US
Hentemann; Martin F. - Hamden CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Grant 9,409,886 - Bencsik , et al. August 9, 2	2016-08-09
Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20160152601 - Bencsik; Josef ; et al.	2016-06-02
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors Grant 9,346,805 - Banka , et al. May 24, 2	2016-05-24
5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors Grant 9,328,091 - Leivers , et al. May 3, 2	2016-05-03
5H-CYCLOPENTA[d]PYRIMIDINES AS AKT PROTEIN KINASE INHIBITORS App 20150266852 - Leivers; Anna ; et al.	2015-09-24
5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors Grant 8,895,566 - Banka , et al. November 25, 2	2014-11-25
Sulfone substituted 2,3-dihydroimidazo [1,2-C] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis Grant 8,859,572 - Hentemann , et al. October 14, 2	2014-10-14
Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20140080829 - Bencsik; Josef ; et al.	2014-03-20
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Grant 08618097 -	2013-12-31
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors Grant 8,618,097 - Bencsik , et al. December 31, 2	2013-12-31
5h-cyclopenta[d]pyrimidines As Akt Protein Kinase Inhibitors App 20130085135 - Banka; Anna ; et al.	2013-04-04
Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20130072500 - Banka; Anna ; et al.	2013-03-21
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors Grant 8,324,221 - Banka , et al. December 4, 2	2012-12-04
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation Grant 7,906,653 - Cantin , et al. March 15, 2	2011-03-15
Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20110053959 - Banka; Anna ; et al.	2011-03-03
Pyrimidyl Cyclopentanes As Akt Protein Kinase Inhibitors App 20110015204 - Bencsik; Josef ; et al.	2011-01-20
Benzofuran derivatives useful for treating hyper-proliferative disorders Grant 7,803,956 - Zhang , et al. September 28, 2	2010-09-28
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation App 20100204472 - Cantin; Louis-David ; et al.	2010-08-12
Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation Grant 7,714,004 - Cantin , et al. May 11, 2	2010-05-11
Pyrimidine Derivatives For Treatment Of Hyperproliferative Disorders App 20100075967 - Dixon; Julie A. ; et al.	2010-03-25
Pyrimidine derivatives for treatment of hyperproliferative disorders Grant 7,678,804 - Dixon , et al. March 16, 2	2010-03-16
Benzofuran Derivatives Useful For Treating Hyper-proliferative Disorders App 20090292014 - Zhang; Chengzhi ; et al.	2009-11-26
Pyrimidine derivatives for treatment of hyperproliferative disorders Grant 7,582,645 - Dixon , et al. September 1, 2	2009-09-01
Benzofuran derivatives useful for treating hyper-proliferative disorders Grant 7,420,066 - Zhang , et al. September 2, 2	2008-09-02
Pyrimidine derivatives for treatment of hyperproliferative disorders App 20070117817 - Dixon; Julie A. ; et al.	2007-05-24
Pyrimidine derivatives for treatment of hyperproliferative disorders App 20050277640 - Dixon, Julie A. ; et al.	2005-12-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.